Company Summary

Lumena Pharma Holdings International Limited was set up on Tuesday the 20th of December 2022. Their current partial address is Cork, and the company status is Dissolved with the company closing on Monday the 2nd of February 2026. The company's current director has been the director of 16 other Irish companies; 9 of which are now closed. Lumena Pharma Holdings International Limited has 1 shareholder.

Company Name:Lumena Pharma Holdings International Limited
Company Status:DISSOLVED
CEASED TRADING NOTIFICATION
Company Address:Penthouse Floor,
5 Lapp's Quay, Cork, Ireland
Key Executive:Ms Nathan
Company Size:Log-In To View
Established:20/12/2022 (4 years in business).

Key Contact Profile

Ms Nathan is a Company Director of Lumena Pharma Holdings International Limited since 2022 and a listed Director of 12 other companies.

Generate a B2B Marketing List with ease and grow your business. Identify key decision makers and pre-qualified new prospects for your sales and business development teams.

Similar Companies - Create a marketing list of similar companies

Latest Updates

The latest documents filed with the Companies Registration Office for Lumena Pharma Holdings International Limited (which can include the Account Details) are listed below.

CRO DocumentEffective DateReceived By CROView Now
Form H15: Application for Voluntary strike-off 14/10/2025Join Up
Letter Of No Objection 14/10/2025Join Up
Advertisement 14/10/2025Join Up
Form B1B73 - Annual Return and Change of ARD20/06/202511/08/2025Join Up
Form B77 - Authorisation/Revocation of an Electronic Filing Agent28/02/202510/03/2025Join Up
THIS COMPANY HAS 9 OTHER DOCS »

View CRO company documents and company reports any Irish company or business with ease.

Credit Report

View the Latest Credit Report and Credit Limit on Lumena Pharma Holdings International Limited.

Company Status:Dissolved
CEASED TRADING NOTIFICATION
Latest Credit Movement:
Date of Last Movement:03/02/2026
Latest Accounts Filed:15/08/2024
Report Based on Accounts:31/12/2023
Next Set of Accounts Due:30/09/2025
Overdue:Yes
Credit Score:Join-Up to View

Full Credit Rating

To View the latest Credit Rating or Credit Limit on Lumena Pharma Holdings International Limited simply click 'Log-In' or 'Join-Up' below.

Vision-net Credit Scores save your business the time and cost of chasing slow payers. Evaluate risk at client application stage or run continuous credit checks on your full customer base.

Directors & Owners

Satisfy due diligence requirements on Lumena Pharma Holdings International Limited in one single 'time-saving' search. Run full background checks for Fitness and Probity on the directors of Lumena Pharma Holdings International Limited and Anti-Money Laundering checks (AML checks) on Lumena Pharma Holdings International Limited

Directors details are available to logged in users.

Ownership Structure

Company Type:LTD - Private Company Limited By Shares
Number of Shareholders:1

Compliance

Log-in now to run Due Diligence checks and Compliance checks on Lumena Pharma Holdings International Limited or click Join-up to get started.

Background check Companies, Sole Traders or Individuals and minimise your spend with more efficient Anti-Money Laundering checks and reports.

Ask Us A Question...?

Strengthening AML Compliance in Ireland

30/03/2026

The EU's sixth Anti-Money Laundering Directive (AMLD6) represents one of the most significant shifts in Europe's financial crime framework in over a decade - with Irish businesses already feeling its impact.

Read More »

Batch Enrichment for Faster Compliance

12/03/2026

Did you know your existing customer records can be enriched with key KYC, AML and risk intelligence through a single, streamlined batch process?

Read More »

Ireland's Directorship Trends: A 2026 Data Snapshot

09/03/2026

As of today, Ireland has over 757,000 company directors, reflecting the scale and complexity of the country?s corporate environment.

Read More »

Ireland's Business Insights Report

27/02/2026

Insights into Start-Up Resilience, Market Challenges and the Changing Risk Environment...

Read More »